Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple sclerosis and vitamin D during pregnancy and lactation.
Fulminant demyelinating diseases.
The Treatment of Lower Urinary Tract Symptoms in Patients With Multiple Sclerosis: A Systematic Review.
The life extension protein Klotho enhances remyelination following cuprizone-induced demyelination
Fingolimod Phosphate Attenuates Oligomeric Amyloid β-Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons.
Remyelination: The True Regeneration of the Central Nervous System.
Progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukaemia treated with alemtuzumab.
Imaging new lesions: Enhancing our understanding of multiple sclerosis pathogenesis.
Role of adenosine in oligodendrocyte precursor maturation.
Metabolic and safety issues for multiple sclerosis pharmacotherapy - opportunities for personalised medicine.
[New therapies in multiple sclerosis].
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
Automatic white matter lesion segmentation using an adaptive outlier detection method.
A randomized clinical trial of valacyclovir in multiple sclerosis.
Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study.
Understanding Tremor in Multiple Sclerosis: Prevalence, Pathological Anatomy, and Pharmacological and Surgical Approaches to Treatment.
Neurocardiogenic Pulmonary Oedema: Initial Presentation of Multiple Sclerosis.
Multiple sclerosis: Etiology, symptoms, incidence and prevalence, and implications for community living and employment.
[Emerging therapies for multiple sclerosis.]
Fenofibrate Inhibited the Differentiation of T Helper 17 Cells In Vitro.
Accelerometry Reveals Differences in Gait Variability Between Patients with Multiple Sclerosis and Healthy Controls.
Cortico-muscular coherence as an index of fatigue in multiple sclerosis.
Network-Based Multiple Sclerosis Pathway Analysis with GWAS Data from 15,000 Cases and 30,000 Controls.
Cognitive functioning and subjective quality of life in relapsing-remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report.
Cognitive assessment in MS.

Pages